文献速递烧伤瘢痕与激光

中重度烧伤患者抗组胺药处方模式分析

Prescription Analysis of Antihistamines' Use in Patients With Moderate to Severe Burns.
PubMed 文献 · J Burn Care Res · 2026-01-01

本研究基于TriNetX全球去标识化数据库,分析过去20年(2004-2024)烧伤面积≥20% TBSA且发生瘙痒患者的抗组胺药处方趋势。共纳入2754例患者,按TBSA分层为20%-40%、40%-60%、60%-80%及≥80%四组,评估处方人数、药物类型及治疗启动、持续和切换时间。超过70%患者接受抗组胺药,羟嗪为最常见一线药物,其次为苯海拉明;各队列启动、持续及切换时间的中位数均值分别为16.75天、90.25天和27.75天。

要点

  • 烧伤≥20% TBSA瘙痒患者中超70%接受抗组胺药,羟嗪最常用。
  • 治疗启动时间中位数均值16.75天,提示关键恢复期症状管理存在差异。
  • 治疗持续时间中位数均值90.25天,切换时间均值27.75天,切换频繁且疗程长。

核心结论

  • 烧伤≥20% TBSA患者抗组胺药使用普遍,但治疗启动时间差异显著,提示关键恢复期症状管理不一致。
  • 频繁切换和较长治疗持续时间提示需要更有效和个体化的治疗策略以优化烧伤后瘙痒管理。

研究设计与样本

  • 采用TriNetX全球联邦去标识化数据库进行治疗路径分析。
  • 纳入过去20年(2004-2024)烧伤≥20% TBSA且发生瘙痒的患者,按TBSA分为20%-40%、40%-60%、60%-80%、≥80%四组。
  • 总样本2754例(20%-40% TBSA n=1712;40%-60% n=613;60%-80% n=253;≥80% n=176)。

主要发现

  • 超过70%患者接受抗组胺药,羟嗪为最常见一线治疗,其次为苯海拉明。
  • 所有队列中,治疗启动、持续及切换时间的中位数均值分别为16.75天、90.25天和27.75天。
  • 治疗启动时间存在显著差异,提示关键恢复期症状管理存在差距。

关键数值与推荐

  • 烧伤面积≥20% TBSA且发生瘙痒的患者纳入分析。
  • 抗组胺药处方评估包括治疗患者数、药物类型及启动、持续、切换时间的中位数。

临床怎么用

  • 烧伤后应警惕瘙痒,定期评估并依据反应逐步升级抗组胺治疗。
  • 需结合辅助策略优化烧伤后瘙痒管理,并关注治疗启动时机。

局限性

  • 基于去标识化数据库的回顾性分析,可能存在未测量的混杂因素。
  • 仅纳入烧伤≥20% TBSA患者,结论外推至轻中度烧伤需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postburn pruritus (PBP) significantly affects patients, causing discomfort and hindering recovery. Antihistamines, which block H1 receptors, are commonly prescribed for PBP, yet large-scale studies on their usage patterns are limited. This study evaluates antihistamine prescription trends and provider practices for PBP across varying burn severities from moderate to severe burns (≥20% TBSA). A treatment-pathways analysis was performed using TriNetX, a global, federated, deidentified database. Patients with burns ≥ 20% TBSA from the past 20 years (2004-2024) who developed pruritus were identified and stratified into 4 cohorts: 20%-40%, 40%-60%, 60%-80%, and ≥ 80% TBSA. The analysis evaluated trends in antihistamine prescriptions, including the number of patients treated with antihistamines, types prescribed, and median times to treatment initiation, duration, and therapy switching. The total sample included 2754 patients (20%-40% TBSA, n = 1712; 40%-60%, n = 613; 60%-80%, n = 253; ≥80%, n = 176). Over 70% received antihistamines, with hydroxyzine as the most common first-line therapy, followed by diphenhydramine. Across all cohorts, the average of the median times for initiation, therapy duration, and time before switching was 16.75 days, 90.25 days, and 27.75 days, respectively. Significant variations in the timing of therapy initiation suggest a gap in consistent symptom management during critical recovery periods, potentially affecting patient comfort and overall outcomes. These findings underscore the importance of vigilant postburn assessment, stepwise escalation based on response, and complementary strategies to optimize PBP management. Frequent switching and prolonged durations suggest a need for more effective and tailored therapeutic approaches to improve recovery outcomes for patients with burn injuries.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Karim AA, Karim N, Shah S, et al. Prescription Analysis of Antihistamines' Use in Patients With Moderate to Severe Burns. J Burn Care Res. 2026. PMID: 41575194. doi:10.1093/jbcr/irag007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。